CLINICAL_TRIALS
trial_result
· 2021-03-26
Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial update for ORMD-0801 in Type 2 diabetes mellitus; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: King Hamad University Hospital, Bahrain | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN